The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
The prevention of type 2 diabetes
Open accessAbstract
Type 2 diabetes mellitus (T2DM) affects more than 7% of adults in the US and leads to substantial personal and economic burden. In prediabetic states insulin secretion and action--potential targets of preventive interventions--are impaired. In trials lifestyle modification (i.e. weight loss and exercise) has proven effective in preventing incident T2DM in high-risk groups, although weight loss has the greatest effect. Various medications (e.g. metformin, thiazolidinediones and acarbose) can also prevent or delay T2DM. Whether diabetes-prevention strategies also ultimately prevent the development of diabetic vascular complications is unknown, but cardiovascular risk factors are favorably affected. Preventive strategies that can be implemented in routine clinical settings have been developed and evaluated. Widespread application has, however, been limited by local financial considerations, even though cost-effectiveness might be achieved at the population level.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our findings that both lifestyle and metformin interventions delayed or prevented diabetes in the DPPOS are consistent with results of other reports of similar interventions with lifestyle or with other antidiabetic drugs.24,25”
From 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study (2009) · cites this paper as [24]
In the citing paper
“In the Diabetes Prevention Program (DPP), metformin reduced the development of diabetes by 31% over an average of 2.8 years of follow-up (4,5).”
From Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study (2012) · cites this paper as [5]
In the citing paper
“additional benefits of the lifestyle intervention that might impact older adults: reduction in urinary incontinence20, improvement in several quality of life domains21, and improvements in cardiovascular risk factors22”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [21]
In the citing paper
“additional benefits of the lifestyle intervention that might impact older adults: reduction in urinary incontinence20, improvement in several quality of life domains21, and improvements in cardiovascular risk factors22”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [22]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Self-citation
Research works printed but not linked: 5
- Holman RR et al. (2007) Results from the early diabetes intervention trials [abstract]. Diabetes 52 (Suppl 1): A16
- Ackermann RT et al. (2007) Translating the Diabetes Prevention Program into the community: the YMCA model [abstract]. Diabetes 67 (Suppl 1): A42
- Ratner R (2004) Community-based identification of pre-diabetes: efficient screening techniques for implementation of diabetes prevention strategies [abstract]. Diabetes 61 (Suppl 1): A290
- Seidel MC et al. (2007) Translating the Diabetes Prevention Program (DPP) in an urban underserved community: long term sustainability of positive clinical outcomes [abstract]. Diabetes 67 (Suppl 1): A42
- Simmons D et al. (1998) A pilot urban church-based programme to reduce risk factors for diabetes among Western Samoans in New Zealand. Diabet Med 15: 136–142 · doi:10.1002/(sici)1096-9136(199802)15:2<136::aid-dia530>3.0.co;2-p
Cited by
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Lack of Exercise Is a Major Cause of Chronic Diseases
Booth, F. W., Roberts, C. K., & Laye, M. J. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110025 · Cited by 2,575
What Influences Saturation? Estimating Sample Sizes in Focus Group Research
Hennink, M. M., Kaiser, B. N., & Weber, M. B. (2019) · Qualitative Health Research · doi:10.1177/1049732318821692 · Cited by 1,162
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181
Metadata
- Authors
- F. T. D. P. P. R. G., Crandall, J. P., Knowler, W. C., Kahn, S. E., Marrero, D., Florez, J. C., Bray, G. A., Haffner, S. M., Hoskin, M., & Nathan, D. M.
- Affiliations
- Albert Einstein College of Medicine (US)
- National Institutes of Health (US)
- VA Puget Sound Health Care System (US)
- Indiana University (US)
- Louisiana State University (US)
- The University of Texas at San Antonio Health Science Center (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Harvard University (US)
- Corresponding author
- Crandall, Jill P
- Venue
- Nature Clinical Practice Endocrinology & Metabolism
- Published
- 2008-05-20
- Volume
- 4
- Issue
- 7
- Pages
- 382-393
- ISSN
- 1745-8366 (ISSN-L)
- 1745-8374
- PMC
- PMC2573045
- OpenAlex
- W2034419419
- Cited by
- 261
- References
- 100
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 16 · 2023: 24 · 2022: 9 · 2021: 20 · 2020: 7 · 2019: 11 · 2018: 9 · 2017: 6 · 2016: 9 · 2015: 18 · 2014: 15 · 2013: 12 · 2012: 28
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (Z01DK069000, U01DK048489)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes prevention, prediabetes, insulin secretion, insulin resistance, lifestyle modification, weight loss, physical activity, metformin, thiazolidinediones, acarbose, cardiovascular risk factors, cost-effectiveness, high-risk groups
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Life Style, Prediabetic State
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The prevention of type 2 diabetes. https://app.cochat.ai/papers/10.1038/ncpendmet0843
- The paper
- F. T. D. P. P. R. G., Crandall, J. P., Knowler, W. C., Kahn, S. E., Marrero, D., Florez, J. C., Bray, G. A., Haffner, S. M., Hoskin, M., & Nathan, D. M. (2008). The prevention of type 2 diabetes. Nature Clinical Practice Endocrinology & Metabolism. https://doi.org/10.1038/ncpendmet0843
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.